Severe Hypoglycemia Archives

FDA Approves First Needle-Free Glucagon to Treat Severe Hypoglycemia

Approvals, FDA, FDA/Regulatory, Glucagon, Medical Devices, Nasal drug delivery, Needle-Free, Peptide Hormones, Severe Hypoglycemia, Type 1 Diabetes, Type 2 Diabetes

The FDA approved Eli Lilly’s Baqsimi (glucagon) nasal powder 3 mg to treat severe hypoglycemia in diabetics 4 years of age and older.

July 25, 2019/by BioSpace

Zealand Pharma’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial

Auto-Injection Therapy, Clinical Trials, Diabetes, R&D, Severe Hypoglycemia, Type 1 Diabetes

Shares of Zealand Pharma A/S were up more than 2 percent after the company announced that dasiglucagon, a potential treatment for severe hypoglycemia, hit the mark in a Phase III study.

May 14, 2019/by BioSpace